Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort-Reference-Cited by-同舟云学术

Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort

Published:2015-04 Issue:4 Volume:21 Page:386.e1-386.e9
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Postorino M.C.,Prosperi M.,Quiros-Roldan E.,Maggiolo F.,Di Giambenedetto S.,Saracino A.,Costarelli S.,Lorenzotti S.,Sighinolfi L.,Di Pietro M.,Torti C.

Funder

Infectious Diseases and International Health Foundation

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference31 articles.

1. Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the use of antiretroviral agents in HIV 1 infected adults and adolescents. Updated 12 February 2014. Available at: http://aidsinfo.nih.gov/guidelines.

2. Class sparing regimens for initial treatment of HIV 1 infection;Riddler;N Engl J Med,2008

3. Comparative effectiveness of initial antiretroviral therapy regimens: ACTG 5095 and 5142 clinical trials relative to ARTCC cohort study;Mugavero;J Acquir Immune DeficSyndr,2011

4. Comparative effectiveness of efavirenz, protease inhibitors, and raltegravir-based regimens as first line treatment for HIV infected adults: a mixed treatment comparison;Vieira;HIV Clin Trials,2011

5. Triple nucleoside regimens versus efavirenz containing regimens for the initial treatment of HIV 1 infection;Gulick;N Engl J Med,2004

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functionalised Dendrimers: Potential Tool for Antiretroviral Therapy;Current Nanoscience;2020-10-05

2. Comparison of Antiretroviral Therapy Regimens in Terms of Virological Response, Immunological Response and Adverse Effects in Treatment-Naive HIV-Positive Patients;Klimik Dergisi/Klimik Journal;2018-07-27

3. Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort;BMC Infectious Diseases;2017-03-15